• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tesla, NIO And Some Other Big Stocks Moving Lower On Tuesday

    12/27/22 11:17:27 AM ET
    $AMC
    $CBD
    $CHRS
    $NIO
    Movies/Entertainment
    Consumer Discretionary
    Food Chains
    Consumer Services
    Get the next $AMC alert in real time by email

    U.S. stocks traded mixed, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

    • WeWork Inc. (NASDAQ:WE) shares tumbled 15% to $1.11.
    • Satixfy Communications Ltd. (NYSE:SATX) fell 12.4% to $5.70.
    • Proterra Inc. (NASDAQ:PTRA) dropped 10.7% to $3.67. Proterra filed for mixed shelf of up to $500 million.
    • SIGNA Sports United N.V. (NYSE:SSU) fell 10.6% to $3.37.
    • Nutex Health Inc. (NASDAQ:NUTX) dropped 10.3% to $1.8650. Benchmark recently initiated coverage on Nutex Health with a Buy rating and announced a price target of $3.
    • Velo3D, Inc. (NYSE:VLD) fell 9.7% to $1.7050.
    • Sonder Holdings Inc. (NASDAQ:SOND) dropped 9.7% to $1.2550.
    • Companhia Brasileira de Distribuição (NYSE:CBD) fell 9.5% to $3.1389.
    • Coherus BioSciences, Inc. (NASDAQ:CHRS) dipped 9.2% to $5.86. Junshi Biosciences and Coherus said that FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA for Toripalimab as treatment for recurrent or metastatic nasopharyngeal carcinoma.
    • Tesla, Inc. (NASDAQ:TSLA) dropped 8.5% to $112.71. Reports suggested the company preponed plans regarding the shutdown of its Giga Shanghai plant. Also, Chinese competitor Nio reduced its Q4 delivery guidance, which could also be negatively impacting Tesla's price action.
    • NIO Inc. (NYSE:NIO) fell 8.2% to $10.07 after the company lowered its Q4 deliveries guidance.
    • Solid Power, Inc. (NASDAQ:SLDP) fell 8% to $2.30. Solid Power recently announced it has deepened its partnership with the BMW Group. Solid Power granted the BMW Group a research and development license to its all-solid-state cell design and manufacturing know-how.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) dropped 6.4% to $4.1172 after dropping 10% on Friday. AMC recently announced a $110 million equity capital raise.

    Also Check This Out Ethereum Falls But Remains Above $1,200; Terra Classic, Quant Among Top Gainers

    Get the next $AMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMC
    $CBD
    $CHRS
    $NIO

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Coherus Oncology Inc.
    $CHRS
    1/23/2026$10.00Outperform
    Oppenheimer
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    Tesla Inc.
    $TSLA
    12/8/2025$425.00Overweight → Equal-Weight
    Morgan Stanley
    NIO Inc.
    $NIO
    11/25/2025Outperform → Neutral
    Macquarie
    More analyst ratings

    $AMC
    $CBD
    $CHRS
    $NIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Oppenheimer initiated coverage on Coherus BioSciences with a new price target

    Oppenheimer initiated coverage of Coherus BioSciences with a rating of Outperform and set a new price target of $10.00

    1/23/26 8:18:28 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMC
    $CBD
    $CHRS
    $NIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bates Jon Christian bought $102,532 worth of shares (750 units at $136.71), increasing direct ownership by 15% to 5,638 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    11/28/25 2:11:24 PM ET
    $NUTX
    Real Estate

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Director Gebbia Joseph bought $1,025,232 worth of shares (4,000 units at $256.31) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/28/25 6:45:17 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AMC
    $CBD
    $CHRS
    $NIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:04:42 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:01:09 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Grenas Cheryl Yvonne

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 12:56:37 PM ET
    $NUTX
    Real Estate

    $AMC
    $CBD
    $CHRS
    $NIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    National CineMedia, Inc. to Release Fourth Quarter and Full Year 2025 Results on February 26, 2026

    National CineMedia, Inc. (NASDAQ:NCMI), the managing member of National CineMedia, LLC ("NCM LLC"), the operator of the largest cinema advertising platform in the U.S., plans to issue its fourth quarter and full year 2025 earnings results after the market closes on Thursday, February 26, 2026. A conference call and audio webcast to discuss the results will take place at 5:00 p.m. Eastern Time. The conference call can be accessed by dialing 1-844-826-3033 or for international participants 1-412-317-5185. Participants should register at least 15 minutes prior to the commencement of the call to register, download, and install necessary audio software. Additionally, a live audio webcast will

    2/19/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

    –The Offering was led by healthcare-dedicated investors including Janus Henderson Investors, HBM Healthcare Investments and Samsara BioCapital– REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. ("Coherus" or the "Company") (NASDAQ:CHRS), today announced the closing of an underwritten public offering of 28,600,000 shares of the Company's common stock (the "Offering"). The shares of common stock were sold at a public offering price of $1.75 per share, before underwriting discounts and commissions. All shares in the Offering were sold by the Company. The gross proceeds to Coherus from the Offering were approximately $50.1 million, before deducting underwriting di

    2/17/26 4:11:28 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

    REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. ("Coherus" or the "Company") (NASDAQ:CHRS), today announced the pricing of an underwritten public offering of 28,600,000 shares of the Company's common stock (the "Offering"). The shares of common stock are being sold at a public offering price of $1.75 per share, before underwriting discounts and commissions. All of the shares in the Offering are being sold by the Company. The gross proceeds to Coherus from the Offering are expected to be approximately $50.1 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30

    2/12/26 9:18:21 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMC
    $CBD
    $CHRS
    $NIO
    SEC Filings

    View All

    Coherus Oncology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Coherus Oncology, Inc. (0001512762) (Filer)

    2/17/26 4:05:33 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 424B5 filed by Coherus Oncology Inc.

    424B5 - Coherus Oncology, Inc. (0001512762) (Filer)

    2/13/26 5:10:53 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    AMC Entertainment Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Filer)

    2/13/26 6:03:41 AM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    $AMC
    $CBD
    $CHRS
    $NIO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMC
    $CBD
    $CHRS
    $NIO
    Leadership Updates

    Live Leadership Updates

    View All

    LAIKA Partners With Fathom Entertainment for Domestic Distribution and FilmNation Entertainment for International Sales on Wildwood

    Confirms October 23, 2026 U.S. Release Date LAIKA, the studio behind Coraline and ParaNorman, announced today that it has partnered with Fathom Entertainment for U.S. theatrical distribution and FilmNation Entertainment for international sales on its upcoming stop-motion feature film Wildwood. The film will open in theaters nationwide on October 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120938376/en/LAIKA Names Fathom Entertainment as US Distributor and FilmNation Entertainment for International Sales for "Wildwood" coming October 23, 2026 The announcement reflects a new phase for LAIKA, as the studio expands

    1/20/26 11:15:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer

    ALISO VIEJO, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a late-stage biopharmaceutical company, today announced the appointment of Jean-Frédéric Viret, Ph.D., as the company's Chief Financial Officer (CFO). Dr. Viret brings over two decades of corporate finance experience in the life sciences industry, leading companies from early-stage clinical development through post-commercialization. At SpyGlass, he will lead the finance and accounting functions as the company advances the Bimatoprost Drug Pad-IOL System (BIM-IOL System) toward late-stage development and potential commercialization. "We are excited to welcome Jean to SpyGlass Pharma as we continue to advance our clin

    1/6/26 8:00:00 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    AMC Theatres Declares Netflix's Stranger Things Series Finale Theatrical Event a Triumph; More Joint Netflix-AMC Cooperation Envisioned in 2026 and Beyond

    Adam Aron, Chairman and CEO of AMC Entertainment (NYSE:AMC), the world's largest theatrical exhibitor, issued the following statement today: "A few months ago, we announced that in September of 2025, a high-level dialogue between AMC and Netflix led to both companies pledging to explore ways to visibly begin working together. This led quickly to AMC showing, in many of its theatres, a Halloween bring-back of Netflix's immensely popular KPop Demon Hunters. It was quite the success. AMC was responsible for more than 35% of all the attendance for KPop Demon Hunters that holiday weekend. So, the two companies immediately turned their focus to what would come next in their mutual cooperation

    1/2/26 9:09:00 AM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    $AMC
    $CBD
    $CHRS
    $NIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Sonder Holdings Inc.

    SC 13D - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:15:36 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G filed by Sonder Holdings Inc.

    SC 13G - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:12:28 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G filed by Sonder Holdings Inc.

    SC 13G - Sonder Holdings Inc. (0001819395) (Subject)

    11/14/24 5:01:29 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    $AMC
    $CBD
    $CHRS
    $NIO
    Financials

    Live finance-specific insights

    View All

    National CineMedia, Inc. to Release Fourth Quarter and Full Year 2025 Results on February 26, 2026

    National CineMedia, Inc. (NASDAQ:NCMI), the managing member of National CineMedia, LLC ("NCM LLC"), the operator of the largest cinema advertising platform in the U.S., plans to issue its fourth quarter and full year 2025 earnings results after the market closes on Thursday, February 26, 2026. A conference call and audio webcast to discuss the results will take place at 5:00 p.m. Eastern Time. The conference call can be accessed by dialing 1-844-826-3033 or for international participants 1-412-317-5185. Participants should register at least 15 minutes prior to the commencement of the call to register, download, and install necessary audio software. Additionally, a live audio webcast will

    2/19/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    Solid Power, Inc. Announces Timing of Full Year 2025 Earnings Release and Conference Call

    Solid Power, Inc. (NASDAQ:SLDP), a leading developer of solid-state battery technology, today announced that it will release its full year 2025 results after market close on Tuesday, February 24, 2026, to be followed by a conference call at 2:30 p.m. MT (4:30 p.m. ET) on the same day. The call may be accessed through a live audio webcast on Solid Power's Investor Relations website at www.solidpowerbattery.com/investor-relations. An audio replay will be available at the same location. About Solid Power Solid Power is developing solid-state battery technology to enable the next generation of batteries for the fast-growing EV and other markets. Solid Power's core technology is its electr

    2/10/26 4:30:00 PM ET
    $SLDP
    Industrial Machinery/Components
    Miscellaneous

    Amcor to report fiscal 2026 second quarter and half year results

    ZURICH, Jan. 20, 2026 /PRNewswire/ -- Amcor plc (NYSE:AMCR, ASX: AMC)) will announce its fiscal 2026 second quarter and half year result for the three and sixth month period ended 31 December 2025 after the US market closes on Tuesday 3 February 2026.   A conference call and webcast to discuss the results will be held at 5.30pm US Eastern Standard Time on Tuesday 3 February 2026 / 9.30am Australian Eastern Daylight Time on Wednesday 4 February 2026.  For those wishing to participate in the call please use the following dial-in numbers: USA:                                       800 715 9871 (toll-free)                                                646 307 1963 (local) Australia:           

    1/20/26 5:00:00 PM ET
    $AMC
    $AMCR
    Movies/Entertainment
    Consumer Discretionary
    Miscellaneous manufacturing industries